All Pathways
EndocrinologyEmergency

Hyperosmolar Hyperglycemic State (HHS) Management

Hyperosmolar Hyperglycemic State (HHS) Management: Suspected HHS → Confirm HHS Diagnosis → 1. Fluid Resuscitation → 2. Insulin Therapy → 3. Potassium St...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected HHS

    Patient with severe hyperglycemia, altered mental status, minimal ketosis

    1. Decision

      Confirm HHS Diagnosis

      All 4 criteria required

      • Glucose ≥600 mg/dL (33.3 mmol/L)
      • Effective osmolality >300 mOsm/kg OR total >320 mOsm/kg
      • β-hydroxybutyrate <3.0 mmol/L OR urine ketones ≤2+
      • pH ≥7.3 AND bicarbonate ≥15 mmol/L
      1. Action

        1. Fluid Resuscitation

        Cornerstone of HHS therapy - prioritize over insulin

        • Initial: 0.9% NaCl 15-20 mL/kg/hr (or 1-1.5L) in first hour
        • 2024 update: Balanced crystalloids (LR/PlasmaLyte) preferred when available
        • Subsequent: Based on corrected sodium and hemodynamics
        • If corrected Na+ high/normal: 0.45% NaCl 250-500 mL/hr
        • If corrected Na+ low: Continue 0.9% NaCl 250-500 mL/hr
        • Goal: Positive fluid balance 3-6L in first 12 hours
        • Smaller boluses (250mL) in elderly/CHF/CKD
        1. Action

          2. Insulin Therapy

          Start AFTER initial fluid bolus - use LOWER dose than DKA

          • Regular insulin 0.05 units/kg/hr IV infusion (HALF the DKA dose)
          • HHS requires less aggressive insulin than DKA
          • Target glucose decline: ≤90-120 mg/dL/hr (slower than DKA)
          • When glucose reaches 250-300 mg/dL: Reduce to 0.02-0.05 units/kg/hr
          • Add dextrose (D5) when glucose <300 mg/dL
          • Rapid glucose/osmolality drop risks cerebral edema
          1. Decision

            3. Potassium Status

            Check K+ before and during insulin

            1. Action

              K+ <3.3 mEq/L

              HOLD insulin until K+ ≥3.3

              • Give 20-40 mEq KCl/L IV fluid
              • Recheck K+ every 1-2 hours
              • Resume insulin when K+ ≥3.3 mEq/L
              1. Action

                4. Continuous Monitoring

                Close laboratory and clinical monitoring

                • Glucose: every 1 hour
                • BMP (Na, K, Cl, HCO3, Cr): every 2-4 hours
                • Osmolality: every 2-4 hours
                • Fluid balance and urine output
                • Mental status assessment
                • Identify and treat precipitating cause
                1. Decision

                  HHS Resolution Criteria?

                  2024 Consensus criteria for resolution

                  • Serum osmolality ≤310 mOsm/kg
                  • Patient alert and oriented
                  • Glucose <250 mg/dL (13.9 mmol/L)
                  1. Action

                    Transition to SubQ Insulin

                    When resolution criteria met and patient eating

                    • Start basal-bolus insulin 1-2 hours BEFORE stopping IV insulin
                    • Calculate total daily dose based on IV insulin requirements
                    • 50% basal, 50% prandial distribution
                    • Do NOT stop IV insulin until SubQ on board
                    1. Outcome

                      HHS Resolved

                      Discharge planning, diabetes education, follow-up

                  2. Action

                    Continue IV Treatment

                    If criteria not met

                    • Continue IV fluids and insulin
                    • Reassess every 2-4 hours
                    • Evaluate for complications
                    • Search for unresolved precipitant
                2. Warning

                  ICU Care Required

                  Severe HHS, hemodynamic instability, altered consciousness

            2. Action

              K+ 3.3-5.3 mEq/L

              Continue insulin, replace K+

              • Add 20-30 mEq KCl per liter IV fluid
              • Maintain K+ 4-5 mEq/L
              • Monitor every 2-4 hours
            3. Action

              K+ >5.3 mEq/L

              Continue insulin, hold K+ replacement

              • Do not add K+ to IV fluids
              • Recheck every 2 hours
              • Begin replacement when K+ <5.3 mEq/L
        2. Warning

          ⚠️ Osmolality Warning

          Avoid rapid correction of osmolality

          • Target decrease: 3 mOsm/kg/hr
          • Rapid correction risks cerebral edema
          • Monitor mental status closely

Guideline Source

Hyperglycemic Crises in Adults With Diabetes: A Consensus Report (ADA/AACE/EASD/JBDS/DTS 2024)

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not address pediatric HHS
  • Does not cover mixed DKA/HHS presentations in detail
  • Requires laboratory monitoring capabilities
  • Does not address underlying precipitant management

Contraindicated Populations

pediatric

Applicable Regions

USEUUK

UK: Aligned with JBDS inpatient care guidelines

US: Based on ADA/AACE consensus recommendations

Version 1Next review: 2028-01-01

Frequently Asked Questions

What is the Hyperosmolar Hyperglycemic State (HHS) Management?

The Hyperosmolar Hyperglycemic State (HHS) Management is a emergency clinical algorithm for Endocrinology. It provides a structured decision tree to guide clinical decision-making, based on Hyperglycemic Crises in Adults With Diabetes: A Consensus Report (ADA/AACE/EASD/JBDS/DTS 2024).

What guideline is the Hyperosmolar Hyperglycemic State (HHS) Management based on?

This algorithm is based on Hyperglycemic Crises in Adults With Diabetes: A Consensus Report (ADA/AACE/EASD/JBDS/DTS 2024) (DOI: 10.2337/dci24-0032).

What are the limitations of the Hyperosmolar Hyperglycemic State (HHS) Management?

Known limitations include: Does not address pediatric HHS; Does not cover mixed DKA/HHS presentations in detail; Requires laboratory monitoring capabilities; Does not address underlying precipitant management. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Hyperosmolar Hyperglycemic State (HHS) Management appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free